John Peter McLaughlin Net Worth & Insider Trades

John Peter McLaughlin - Director, Pdl Biopharma, Inc

As of December 22, 2020

What is John Peter McLaughlin's Net Worth?

The current estimated net worth of Pdl Biopharma, Inc's Director, John Peter McLaughlin, is estimated to be about $9.22M . John Peter McLaughlin owns about 200,000 units of Pdl Biopharma, Inc common stock. In the last 5 years at Pdl Biopharma, Inc, John Peter McLaughlin has sold an estimated value of $855.77K worth.

What is John Peter McLaughlin's Past Insider Trading?

John Peter McLaughlin's largest sale order was 327,934 units , worth over $855.77K on December 22, 2020. In total, John Peter McLaughlin has made about 11 transactions over 5 years of their time at Pdl Biopharma, Inc. John Peter McLaughlin usually trades in December, with the busiest year in 2020, 2016, 2018, 2019 and 2017.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

John Peter McLaughlin

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is John Peter McLaughlin's' Mailing Address?

  • Mailing address is C/o Pdl Biopharma, Inc. 932 Southwood Boulevard Incline Village NV 89451 NV

What are Pdl Biopharma, Inc's Past Insider Trades?

Pdl Biopharma, Inc's most recent insider trade came on December 31, 2020 by David W Gryska who sold 20,000 units worth $54.8K . In the last 5 years, insiders at Pdl Biopharma, Inc have sold an estimated value of $6.69M and bought an estimated value of $29.52M worth of shares. Insider trading is most common in June, with the busiest year in 2020. The most active traders at the company are Christopher Stone, VP,  Peter S Garcia, Vice President,  and David W Gryska, Director .

PDL BIOPHARMA, INC. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...